These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. [Advances in alpha-adrenoceptors research]. Qian JQ Sheng Li Ke Xue Jin Zhan; 1988 Jan; 19(1):57-60. PubMed ID: 2839899 [No Abstract] [Full Text] [Related]
44. Proceedings of a workshop on alpha-adrenoceptors. Loch Lomond, 27-28 July 1984. Clin Sci (Lond); 1985; 68 Suppl 10():1S-161S. PubMed ID: 2982535 [No Abstract] [Full Text] [Related]
45. Elucidation of the profound antagonism of contractile action of phenylephrine in rat aorta effected by an atypical sympathomimetic decongestant. Rizvić E; Janković G; Savić MM Korean J Physiol Pharmacol; 2017 Jul; 21(4):385-395. PubMed ID: 28706452 [TBL] [Abstract][Full Text] [Related]
46. Atypical sympathomimetic drug lerimazoline mediates contractile effects in rat aorta predominantly by 5-HT2A receptors. Rizvić E; Janković G; Kostić-Rajačić S; Savić MM Bosn J Basic Med Sci; 2017 Aug; 17(3):194-202. PubMed ID: 28628756 [TBL] [Abstract][Full Text] [Related]
47. Acute dilation to alpha(2)-adrenoceptor antagonists uncovers dual constriction and dilation mediated by arterial alpha(2)-adrenoceptors. Crassous PA; Flavahan S; Flavahan NA Br J Pharmacol; 2009 Nov; 158(5):1344-55. PubMed ID: 19785657 [TBL] [Abstract][Full Text] [Related]
48. Regulation of vascular reactivity in scleroderma: new insights into Raynaud's phenomenon. Flavahan NA Rheum Dis Clin North Am; 2008 Feb; 34(1):81-7; vii. PubMed ID: 18329534 [TBL] [Abstract][Full Text] [Related]
49. Pharmacological characterization of the postsynaptic alpha-adrenoceptors in isolated canine mesenteric arteries and veins. Itoh H; Kohli JD; Rajfer SI Naunyn Schmiedebergs Arch Pharmacol; 1987 Jan; 335(1):44-9. PubMed ID: 2883585 [TBL] [Abstract][Full Text] [Related]
50. Alpha-adrenergic receptors in human blood vessels. van Brummelen P; Jie K; van Zwieten PA Br J Clin Pharmacol; 1986; 21 Suppl 1(Suppl 1):33S-39S. PubMed ID: 2871855 [TBL] [Abstract][Full Text] [Related]
51. Comparison of activity of alpha-adrenoceptor agonists and antagonists in dog and rabbit saphenous vein. Alabaster VA; Keir RF; Peters CJ Naunyn Schmiedebergs Arch Pharmacol; 1985 Jul; 330(1):33-6. PubMed ID: 2864638 [TBL] [Abstract][Full Text] [Related]
52. The influence of atherosclerosis on the mechanical responses of human isolated coronary arteries to substance P, isoprenaline and noradrenaline. Berkenboom G; Depierreux M; Fontaine J Br J Pharmacol; 1987 Sep; 92(1):113-20. PubMed ID: 2444299 [TBL] [Abstract][Full Text] [Related]
53. Subtypes of alpha-adrenoceptors in contraction of vascular smooth muscle. Minneman KP; Esbenshade TA; Han C Jpn J Pharmacol; 1992; 58 Suppl 2():128P-134P. PubMed ID: 1324334 [No Abstract] [Full Text] [Related]
54. Alpha 1- and alpha 2-adrenoceptors: pharmacology and clinical implications. Starke K; Docherty JR J Cardiovasc Pharmacol; 1981; 3 Suppl 1():S14-23. PubMed ID: 6169956 [No Abstract] [Full Text] [Related]